BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 1685836)

  • 1. Flow cytometric DNA analysis of primary cutaneous malignant melanoma.
    Ohnishi K; Ishikawa H
    Acta Derm Venereol; 1991; 71(6):525-8. PubMed ID: 1685836
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Significance of DNA abnormalities in primary malignant melanoma and nevi, a retrospective flow cytometric study.
    von Roenn JH; Kheir SM; Wolter JM; Coon JS
    Cancer Res; 1986 Jun; 46(6):3192-5. PubMed ID: 3698035
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of DNA ploidy and degree of DNA abnormality in benign and malignant melanocytic lesions of the skin using video imaging.
    Pilch H; Günzel S; Schäffer U; Tanner B; Heine M
    Cancer; 2000 Mar; 88(6):1370-7. PubMed ID: 10717619
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DNA ploidy in malignant melanoma, skin cancer and pigmented nevi.
    Skowronek J; Adamska K; Filipiak K; Karaś Z; Krenz RM; Rutkowski R; Warchoł JB
    Neoplasma; 1997; 44(5):282-8. PubMed ID: 9473786
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Applications of DNA flow cytometry and fluorescence in situ hybridization using a chromosome-specific DNA probe on paraffin-embedded tissue sections of primary malignant melanomas.
    Matsuta M; Imamura Y; Matsuta M; Kon S; Sasaki K
    J Dermatol; 1994 Jan; 21(1):14-9. PubMed ID: 8157816
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is DNA ploidy of prognostic significance in stage I cutaneous melanoma?
    Gattuso P; Reddy V; Solans E; Kathuria S; Aranha GV; Jacobs HK; Walloch J
    Surgery; 1990 Oct; 108(4):702-8; discussion 708-9. PubMed ID: 2218882
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Histopathology, morphometry, and nuclear DNA content of iris melanocytic lesions.
    Grossniklaus HE; Oakman JH; Cohen C; Calhoun FP; DeRose PB; Drews-Botsch C
    Invest Ophthalmol Vis Sci; 1995 Mar; 36(3):745-50. PubMed ID: 7890505
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of image analysis with flow cytometry for DNA content analysis in pigmented lesions of the skin.
    Sangueza OP; Hyder DM; White CR; Pallander J; Perkins M; Remple N; Bakke A
    Anal Quant Cytol Histol; 1992 Feb; 14(1):55-9. PubMed ID: 1558616
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Examination of DNA-ploidy in melanocytic nevi cells using video-imaging cytometry.
    Skowronek J; Filipiak K; Karaś Z; Krenz RM; Włodarczyk H
    Pol J Pathol; 1997; 48(1):37-41. PubMed ID: 9200959
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Flow cytometric DNA content analysis on squamous cell carcinomas according to the preceding lesions.
    Tamura A; Ohnishi K; Ishikawa O; Miyachi Y
    Br J Dermatol; 1996 Jan; 134(1):40-3. PubMed ID: 8745884
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Immunohistochemical analysis of ras gene expression in human melanomas and melanocytic nevi].
    Yasuda H
    Hokkaido Igaku Zasshi; 1989 May; 64(3):243-53. PubMed ID: 2670726
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DNA index and % S phase fraction in posterior uveal melanoma: a 5 year prospective study of fresh tissue using flow cytometry.
    Richardson RP; Lawry L; Rees RC; Rennie IG
    Eye (Lond); 1997; 11 ( Pt 5)():629-34. PubMed ID: 9474308
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DNA image cytometry on sections as compared with image cytometry on smears and flow cytometry in melanoma.
    Klapperstück T; Wohlrab W
    Cytometry; 1996 Sep; 25(1):82-9. PubMed ID: 8875057
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Unusual and unknown aspect of cutaneous malignant melanoma: minimal deviation malignant melanoma. Retrospective study of 45 cases].
    Mérot Y; Mihm MC
    Ann Dermatol Venereol; 1985; 112(4):325-36. PubMed ID: 4026131
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Flow DNA-cytometric findings of paraffin-embedded primary cutaneous melanomas related to prognosis.
    Lindholm C; Hofer PA; Jonsson H; Tribukait B
    Virchows Arch B Cell Pathol Incl Mol Pathol; 1989; 58(2):147-51. PubMed ID: 2575819
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Nevus associated malignant melanomas--diagnostic validation and prognosis].
    Stadler R; Garbe C
    Hautarzt; 1991 Jul; 42(7):424-9. PubMed ID: 1938395
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Classifying melanocytic tumors based on DNA copy number changes.
    Bastian BC; Olshen AB; LeBoit PE; Pinkel D
    Am J Pathol; 2003 Nov; 163(5):1765-70. PubMed ID: 14578177
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Favorable prognosis for malignant melanomas associated with acquired melanocytic nevi.
    Friedman RJ; Rigel DS; Kopf AW; Lieblich L; Lew R; Harris MN; Roses DF; Gumport SL; Ragaz A; Waldo E; Levine J; Levenstein M; Koenig R; Bart RS; Trau H
    Arch Dermatol; 1983 Jun; 119(6):455-62. PubMed ID: 6859885
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparative study of proliferation indices and ploidy in dysplastic naevi and malignant melanomas using flow cytometry.
    Slater SD; Cook MG; Fisher C; Wright NA; Foster CS
    Histopathology; 1991 Oct; 19(4):337-44. PubMed ID: 1937413
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Allelic imbalance in the diagnosis of benign, atypical and malignant Spitz tumours.
    van Dijk MC; Rombout PD; Mooi WJ; van de Molengraft FJ; van Krieken JH; Ruiter DJ; Ligtenberg MJ
    J Pathol; 2002 Jun; 197(2):170-8. PubMed ID: 12015740
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.